enVVeno Medical Corporation Common Stock
$9.05
-$0.27 (-2.90%)
$7.01Day Range$9.44
Key Statistics
Market Cap
$6.29M
Shares Outstanding
0.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 31, 2018
Round Lot
100
Locale
US
Trading Data
Day Open
$9.42
Day High
$9.44
Day Low
$7.01
Volume
39.3K
VWAP
$8.69
Prev Close
$9.32
Transactions
--
Acc. Volume
--
About enVVeno Medical Corporation Common Stock
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 384133 employees70 DOPPLER, IRVINE, CA, 92618949-261-2900IPO May 31, 2018US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001661053
- Composite FIGI
- BBG000PVDC20
- Share Class FIGI
- BBG001SRG4B9
- Ticker Root
- NVNO
- SIC Code
- 3841
About enVVeno Medical Corporation Common Stock (NVNO) Stock
enVVeno Medical Corporation Common Stock (NVNO) closed the 2026-09-16 session at $9.05, down 2.90% versus the previous close (-0.27). The stock opened at $9.42 and traded between $7.01 and $9.44 during that session. Session trading volume was 39K shares. The volume-weighted average price (VWAP) is $8.69.
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
enVVeno Medical Corporation Common Stock has a market capitalization of $6.3 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. NVNO is listed on the XNAS exchange. The company employs approximately 33 people. enVVeno Medical Corporation Common Stock is headquartered in IRVINE, CA. The recorded listing date is 2018-05-31.
On this page you can find market NVNO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.